MyTelemedicine Launches Coronavirus Covid-19 Self-Assessment Tool


Telehealth industry leader MyTelemedicine announced the release of a COVID-19 Coronavirus Self-Assessment Tool, designed to help people determine whether to seek immediate medical care and connect them via video call with a licensed doctor nationwide.

Available through both the MyTelemedicine online health portal and mobile app, the COVID-19 Self-Assessment Tool takes users through a series of diagnostic questions to determine whether they are experiencing symptoms of COVID-19.  Those showing signs are immediately directed to initiate a consultation with a virtual physician for further evaluation via the MyTelemedicine video platform. Members also are provided with key CDC resources to assist them with next steps. Those users who do not show signs or symptoms of Coronavirus still will have the option to initiate a video visit.

"Our goal is to help flatten the curve and keep people safe," says Rey Colon, CEO and Founder of MyTelemedicine. He adds, "The more consumers we can assist here in the U.S., the better we can prevent the spread of the disease and protect the health of the population as a whole."

On the heels of the President's public address at the White House earlier this week, the Trump Administration announced expanded telehealth coverage for Medicare recipients, allowing them to receive vital services from healthcare practitioners without having to leave home. Although telemedicine platforms have been available for several years, the outbreak of Coronavirus may create a tipping point to hasten rapid adoption of telehealth technology services by consumers and providers nationwide.

MyTelemedicine has been a leader in the virtual healthcare space since it was founded in 2015. The company uses cloud-based technologies to connect members with U.S. licensed doctors 24/7 via phone, email, or video conference. MyTelemedicine also offers Spanish-language telehealth services for users to consult with fully licensed, Spanish-speaking physicians nationwide. 

"We are always striving to innovate with purpose, and our new COVID-19 Self-Assessment Tool is one of the ways that we can leverage technology for the greater good," says Chief Technology Officer Jesse Roach.

The COVID-19 Self-Assessment Tool can be accessed through the MyTelemedicine online portal, as well as through the Access a Doctor mobile app, which is available both in the iTunes Store and Google Play. MyTelemedicine plans to roll out additional functionalities to the self-assessment tool in the coming days, including a directory of testing locations nationwide. Says CEO Rey Colon, "Even after COVID-19 goes away, tools like this and telemedicine as a whole will change the way we use healthcare."   

For more information please visit www.mytelemedicine.com.



March 25, 2020


Topic Area: Press Release


Recent Posts

Waco Family Medicine Achieves Savings and Bold Design with Wood Selections

Case study: The healthcare facility incorporated over 25,000 square feet of wood and saved over $400,000.


Alleged Ransomware Administrator Extradited from South Korea

The Phobos ransomware has been used globally to target over 1,000 organizations, including healthcare.


Design Plans Unveiled for New Intermountain St. Vincent Regional Hospital

The new hospital will be a 14-floor, 737,000 square-foot facility in Billings, Montana.


Ground Broken on New Pediatric Health Campus in Dallas

The new campus will replace the existing Children’s Medical Center Dallas.


Pre-Construction Strategies for Successful Facilities Projects

Savvy decisions can help facilities meet long-term goals by creating consistency and eliminating waste.


 
 


FREE Newsletter Signup Form

News & Updates | Webcast Alerts
Building Technologies | & More!

 
 
 


All fields are required. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

 
 
 
 

Healthcare Facilities Today membership includes free email newsletters from our facility-industry brands.

Facebook   Twitter   LinkedIn   Posts

Copyright © 2023 TradePress. All rights reserved.